Pharmaceutical

LimmaTech secures funding for vaccine technology development

LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.

Feb 2, 2024 - 18:00
LimmaTech secures funding for vaccine technology development
LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.
Read the original article

Tags:

Previous Article

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Next Article

Biosyngen’s liver cancer therapy receives fast track designation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Cancun abortion clinic aims to serve Americans from restrictive states

Cancun abortion clinic aims to serve Americans from res...

Nov 9, 2023

STAT+: A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys

STAT+: A looming cancer vaccine test for Gritstone Bio,...

Feb 9, 2024

TLM-004 by Therillume for Glioblastoma Multiforme (GBM)...

Nov 6, 2023